series-a
Stage
1
Investors
About
PleoPharma, Inc. is a clinical-stage pharmaceutical company developing treatments for central nervous system and substance abuse disorders, with a focus on cannabis-related health issues; its lead program has completed Phase 2 clinical trials.
Explore PleoPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.